查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1725188

痔疮治疗市场预测至 2032 年：按产品类型、治疗类型、疾病类型、分销管道、最终用户和地区进行的全球分析

Hemorrhoid Treatment Market Forecasts to 2032 - Global Analysis By Product Type, Treatment Type, Disease Type, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球痔疮治疗市场预计在 2025 年达到 12 亿美元，到 2032 年将达到 20.7 亿美元，预测期内的复合年增长率为 8.10%。

痔疮治疗是指对直肠和肛门内肿胀和发炎的静脉（通常称为痔疮）进行药物治疗或手术治疗。治疗方案取决于严重程度，可能包括改变生活方式，例如增加纤维摄取量以促进排便和饮用足够的液体。非处方药膏、软膏和塞剂可以帮助缓解搔痒和不适。在更严重的情况下，可以进行橡皮筋结扎、硬化疗法和红外线凝固等手术。在极少数情况下，可能需要手术切除（切除术）。早期治疗和预防护理对于缓解症状、改善生活品质和避免出血和感染等併发症至关重要。

根据美国卫生研究院（NIH）2021年发表的一篇论文，全球一般人群痔疮盛行率估计为4.4%。

痔疮盛行率不断上升

痔疮盛行率的上升极大地推动了痔疮治疗市场的成长。久坐的生活方式、人口老化和饮食习惯等因素导致病例增加，增加了对有效治疗的需求。这种普及促进了微创手术和商业化产品的进步，提高了患者的可及性和舒适度。此外，人们意识的提高和耻辱感的减少正在鼓励更多的人寻求医疗干预，从而进一步扩大市场。

社会耻辱与尴尬

痔疮治疗与羞耻和社会耻辱有关，这严重阻碍了市场的成长。相当多的人不愿意寻求治疗，因为他们认为这是一种社会禁忌，并且不愿意谈论此类症状。这导致诊断和治疗被推迟，从而减少了对痔疮相关服务和产品的需求。这种危害在保守社会中尤其明显，人们可能会选择自我护理或忽视症状，这限制了市场潜力并阻碍了有效治疗方法的采用。

非处方药的供应

由于非处方药 (OTC) 的可用性、可负担性以及消费者的自主性，痔疮治疗市场蓬勃发展。无需处方笺即可购买的产品（例如药膏和塞剂）可以轻鬆、非侵入性地缓解症状。这鼓励自我治疗并减少痔疮的羞耻感。这一趋势是由零售店和网路药局的成长所推动的，它们允许谨慎购买并有助于扩大市场。此外，人们的健康意识不断增强，推动了非处方药需求的增加，刺激了技术创新和製造商之间的竞争。

医疗费用高昂

痔疮治疗市场受到高昂治疗费用的不利影响，这限制了许多人获得治疗的机会，尤其是在新兴市场。这些费用可能会阻止患者寻求及时治疗，可能导致症状和併发症恶化。此外，治疗费用可能无法完全由保险承担，这阻碍了市场的成长。因此，患者可能会转向较便宜但效果较差的治疗方案，进而影响整体治疗接受率。

COVID-19的影响

由于医疗资源被重新用于对抗病毒，COVID-19 疫情对痔疮治疗市场产生了重大影响。许多选择性手术，包括痔疮手术，都被延迟或取消，导致护理需求减少。然而，远端医疗的兴起提供了替代方案，随着医疗保健系统适应新常态，市场逐渐復苏。

预测期内，血栓性痔疮预计将成为最大的细分市场

由于医疗干预的紧迫性，通常需要手术或微创手术，预计血栓性痔疮将在预测期内占据最大的市场占有率。诊断率的上升和患者寻求治疗的意愿的增强正在推动对先进治疗的需求。非侵入性治疗和疼痛管理方案的创新将进一步推动市场成长。血栓性痔疮常常引起严重的症状，导致医疗专业人员的数量增加，大大促进了整个痔疮治疗市场的扩张。

预计在预测期内，医院部门的复合年增长率最高。

由于拥有先进的医疗基础设施、熟练的医务人员和微创手术，预计医院部门将在预测期内实现最高成长。该医院将作为主要的诊断和治疗中心，确保患者得到及时和准确的治疗。此外，因手术和非手术痔疮治疗而入院的人数不断增加也推动了需求的成长。将尖端技术与全面的术后护理相结合，进一步改善治疗效果，使医院成为市场扩张的主要贡献者。

比最大的地区

在预测期内，由于人们对肛门健康的认识不断提高、医疗保健基础设施不断改善以及对微创治疗的需求不断增加，预计亚太地区将占据最大的市场占有率。人口老化、久坐的生活方式和饮食习惯导致痔疮患病率上升，从而推动了市场扩张。政府和私人公司正在投资先进的医疗技术和推广计划，以改善患者的治疗效果和获得医疗服务的机会。这种成长正在推动创新并加强该地区的整体医疗保健生态系统。

复合年增长率最高的地区：

预计北美地区在预测期内将呈现最高的复合年增长率。这是由于老年人口不断增长以及先进的微创治疗方案的出现。技术进步、医疗支出的增加以及医疗设施的改善提高了早期诊断和有效管理。此外，优惠的报销政策和主要市场参与者的强大影响力正在推动市场成长，而与生活方式相关的风险因素则进一步刺激需求，整体上形成了充满活力且不断扩大的治疗格局。

免费客製化服务

订阅此报告的客户可享有以下免费自订选项之一：

  • 公司简介
    • 对其他市场公司（最多 3 家公司）进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 地理细分
    • 根据客户兴趣对主要国家市场进行估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 研究范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 限制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球痔疮治疗市场（依产品类型）

  • 场外交易（OTC）
  • 处方药
  • 医疗设备
  • 外科产品
  • 其他产品类型

6. 全球痔疮治疗市场（依治疗类型）

  • 药物治疗
    • 局部治疗
    • 口服药物
    • 栓剂
  • 微创手术
    • 硬化疗法
    • 橡皮筋结扎
    • 红外线凝固术（IRC）
    • 冷冻疗法
  • 手术治疗
    • 切除术
    • 痔疮固定术

第七章全球痔疮治疗市场（依疾病类型）

  • 内痔
  • 外痔
  • 血栓性痔疮

8. 全球痔疮治疗市场（依分销管道）

  • 药局和药局
  • 网路药局
  • 医疗保健中心

第九章全球痔疮治疗市场（按最终用户）

  • 医院
  • 诊所
  • 门诊手术中心（ASC）
  • 居家护理
  • 远端医疗提供者
  • 其他最终用户

第 10 章全球痔疮治疗市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十二章 公司概况

  • Johnson & Johnson
  • Bausch Health Companies Inc.
  • Pfizer Inc.
  • Church & Dwight Co., Inc.
  • Takeda Pharmaceutical Company Limited
  • Sanofi
  • GlaxoSmithKline plc
  • AbbVie Inc.
  • Novartis AG
  • Bayer AG
  • Reckitt Benckiser Group plc
  • Sun Pharmaceutical Industries Limited
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Limited
  • Perrigo Company plc
  • Proctortec Ltd.
  • Medtronic plc
  • Boston Scientific Corporation
Product Code: SMRC29334

According to Stratistics MRC, the Global Hemorrhoid Treatment Market is accounted for $1.20 billion in 2025 and is expected to reach $2.07 billion by 2032 growing at a CAGR of 8.10% during the forecast period. Hemorrhoid treatment refers to the medical or surgical management of swollen and inflamed veins in the rectum or anus, commonly known as piles. Treatment options vary depending on severity and may include lifestyle changes, such as increased fiber intake and proper hydration, to ease bowel movements. Over-the-counter creams, ointments, and suppositories can reduce itching and discomfort. For more severe cases, procedures like rubber band ligation, sclerotherapy, or infrared coagulation may be performed. In rare cases, surgical removal (hemorrhoidectomy) is necessary. Early treatment and preventive care are essential to alleviate symptoms, improve quality of life, and avoid complications such as bleeding or infection.

according to an article published by the National Institutes of Health (NIH) in 2021, the estimated worldwide prevalence of hemorrhoids in the general population was estimated to be 4.4%.

Market Dynamics:

Driver:

Rising Prevalence of Hemorrhoids

The rising prevalence of hemorrhoids is significantly propelling the growth of the hemorrhoid treatment market. Factors such as sedentary lifestyles, aging populations, and dietary habits contribute to increased cases, leading to heightened demand for effective treatments. This surge has spurred advancements in minimally invasive procedures and over-the-counter products, enhancing patient accessibility and comfort. Additionally, growing awareness and reduced stigma encourage more individuals to seek medical intervention, further expanding the market.

Restraint:

Social Stigma and Embarrassment

The treatment of hemorrhoids is associated with feelings of shame and social stigma, and this serves to greatly impede the growth of the market. A significant number of people refrain from pursuing treatment because they perceive a social taboo and feel uneasy about talking about such conditions. This hesitance postpones diagnosis and therapy, leading to a decreased need for hemorrhoid-related services and products. This detrimental effect is particularly evident in conservative societies, where people might choose self-care or overlook symptoms, thus constraining market potential and hindering the adoption of effective treatments.

Opportunity:

Availability of Over-the-Counter (OTC) Medications

The hemorrhoid treatment market has been significantly advanced by the accessibility, affordability, and consumer autonomy provided by over-the-counter (OTC) medications. Products available without a prescription, such as ointments and suppositories, provide simple and non-invasive relief. This fosters self-treatment and diminishes the stigma around hemorrhoids. The growth of retail and online pharmacies, which allow for discreet purchases and contribute to market expansion, supports this trend. Furthermore, the growing health consciousness have resulted in a heightened demand for OTC options, prompting innovation and rivalry among producers.

Threat:

High Treatment Costs

The market for hemorrhoid treatment is adversely affected by the high costs of treatment, which restrict accessibility for a large segment of the population, especially in developing areas. These costs can discourage patients from pursuing prompt medical treatment, resulting in aggravated symptoms or complications. Furthermore, the costs of treatment might not be completely compensated by insurance coverage, which hampers market growth. Consequently, patients might resort to less costly but also less effective options, which impacts the overall rates of treatment adoption.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the hemorrhoid treatment market as healthcare resources were redirected towards combating the virus. Many elective procedures, including hemorrhoid surgeries, were postponed or canceled, leading to a decline in treatment demand. However, the rise in telemedicine and at-home treatments, such as over-the-counter medications and non-invasive therapies, provided an alternative, helping the market recover gradually as healthcare systems adapted to the new normal.

The thrombosed hemorrhoids segment is expected to be the largest during the forecast period

The thrombosed hemorrhoids segment is expected to account for the largest market share during the forecast period, due to its urgent need for medical intervention, often requiring surgical or minimally invasive procedures. Rising diagnosis rates, and greater patient willingness to seek treatment are boosting demand for advanced therapies. Innovations in non-invasive treatments and pain management options further enhance market growth. As thrombosed hemorrhoids often present with severe symptoms, they lead to higher healthcare engagement, significantly contributing to the overall expansion of hemorrhoid treatment market.

The hospitals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the hospitals segment is predicted to witness the highest growth rate, due to advanced medical infrastructure, skilled healthcare professionals, and the availability of minimally invasive procedures. Hospitals serve as primary centers for diagnosis and treatment, ensuring timely and accurate care for patients. Additionally, increasing patient admissions for surgical and non-surgical hemorrhoid treatments boost demand. The segment's integration of cutting-edge technologies and comprehensive postoperative care further enhances treatment outcomes, positioning hospitals as key contributors to the market's expansion.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share due to rising awareness of anorectal health, improving healthcare infrastructure, and increasing demand for minimally invasive treatments. Aging populations, sedentary lifestyles, and dietary habits have contributed to a higher incidence of hemorrhoids, fueling market expansion. Governments and private players are investing in advanced medical technologies and outreach programs, enhancing patient outcomes and access to care. This growth is fostering innovation and strengthening the region's overall healthcare ecosystem.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to increasing geriatric population, and the availability of advanced, minimally invasive treatment options. Technological advancements, growing healthcare expenditure, and improved access to medical facilities are enhancing early diagnosis and effective management. Additionally, favorable reimbursement policies and strong presence of key market players are accelerating market growth, while lifestyle-related risk factors further fuel demand, collectively shaping a dynamic and expanding treatment landscape.

Key players in the market

Some of the key players profiled in the Hemorrhoid Treatment Market include Johnson & Johnson, Bausch Health Companies Inc., Pfizer Inc., Church & Dwight Co., Inc., Takeda Pharmaceutical Company Limited, Sanofi, GlaxoSmithKline plc, AbbVie Inc., Novartis AG, Bayer AG, Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Limited, Cipla Ltd., Dr. Reddy's Laboratories Ltd., Glenmark Pharmaceuticals Limited, Perrigo Company plc, Proctortec Ltd., Medtronic plc and Boston Scientific Corporation.

Key Developments:

In April 2025, ConcertAI announced a multi-year strategic agreement with Bayer AG aimed at accelerating clinical development in precision oncology. Through this partnership, Bayer will leverage ConcertAI's Translational360(TM) platform and AI SaaS solutions, which integrate multi-modal real-world data-including clinical, genomic, transcriptomic, and imaging data-to enhance oncology research and development.

In February 2025, Planet Labs PBC and Bayer have expanded their strategic partnership through a multi-year enterprise license agreement, enhancing Bayer's access to Planet's satellite imagery and analytics. This collaboration aims to accelerate digital innovation in agriculture by enabling Bayer to make data-driven decisions across its global operations.

In October 2024, Bayer and MOMA Therapeutics have entered into a collaboration and exclusive license agreement to develop and commercialize a small molecule oncology program utilizing MOMA's proprietary KNOMATIC(TM) platform. This partnership aims to advance precision oncology treatments by targeting highly dynamic proteins, which are emerging as critical players in cancer progression.

Product Types Covered:

  • Over-the-counter (OTC) Products
  • Prescription Medications
  • Medical Devices
  • Surgical Products
  • Other Product Types

Treatment Types Covered:

  • Pharmacological Treatments
  • Minimally Invasive Procedures
  • Surgical Treatments

Disease Types Covered:

  • Internal Hemorrhoids
  • External Hemorrhoids
  • Thrombosed Hemorrhoids

Distribution Channels Covered:

  • Pharmacies and Drugstores
  • Online Pharmacies
  • Healthcare Centers

End Users Covered:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Home Care
  • Telemedicine Providers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Hemorrhoid Treatment Market, By Product Type

  • 5.1 Introduction
  • 5.2 Over-the-counter (OTC) Products
  • 5.3 Prescription Medications
  • 5.4 Medical Devices
  • 5.5 Surgical Products
  • 5.6 Other Product Types

6 Global Hemorrhoid Treatment Market, By Treatment Type

  • 6.1 Introduction
  • 6.2 Pharmacological Treatments
    • 6.2.1 Topical Treatments
    • 6.2.2 Oral Medications
    • 6.2.3 Suppositories
  • 6.3 Minimally Invasive Procedures
    • 6.3.1 Sclerotherapy
    • 6.3.2 Rubber Band Ligation
    • 6.3.3 Infrared Coagulation (IRC)
    • 6.3.4 Cryotherapy
  • 6.4 Surgical Treatments
    • 6.4.1 Hemorrhoidectomy
    • 6.4.2 Stapled Hemorrhoidopexy

7 Global Hemorrhoid Treatment Market, By Disease Type

  • 7.1 Introduction
  • 7.2 Internal Hemorrhoids
  • 7.3 External Hemorrhoids
  • 7.4 Thrombosed Hemorrhoids

8 Global Hemorrhoid Treatment Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Pharmacies and Drugstores
  • 8.3 Online Pharmacies
  • 8.4 Healthcare Centers

9 Global Hemorrhoid Treatment Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Clinics
  • 9.4 Ambulatory Surgical Centers (ASCs)
  • 9.5 Home Care
  • 9.6 Telemedicine Providers
  • 9.7 Other End Users

10 Global Hemorrhoid Treatment Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Johnson & Johnson
  • 12.2 Bausch Health Companies Inc.
  • 12.3 Pfizer Inc.
  • 12.4 Church & Dwight Co., Inc.
  • 12.5 Takeda Pharmaceutical Company Limited
  • 12.6 Sanofi
  • 12.7 GlaxoSmithKline plc
  • 12.8 AbbVie Inc.
  • 12.9 Novartis AG
  • 12.10 Bayer AG
  • 12.11 Reckitt Benckiser Group plc
  • 12.12 Sun Pharmaceutical Industries Limited
  • 12.13 Cipla Ltd.
  • 12.14 Dr. Reddy's Laboratories Ltd.
  • 12.15 Glenmark Pharmaceuticals Limited
  • 12.16 Perrigo Company plc
  • 12.17 Proctortec Ltd.
  • 12.18 Medtronic plc
  • 12.19 Boston Scientific Corporation

List of Tables

  • Table 1 Global Hemorrhoid Treatment Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Hemorrhoid Treatment Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Hemorrhoid Treatment Market Outlook, By Over-the-counter (OTC) Products (2024-2032) ($MN)
  • Table 4 Global Hemorrhoid Treatment Market Outlook, By Prescription Medications (2024-2032) ($MN)
  • Table 5 Global Hemorrhoid Treatment Market Outlook, By Medical Devices (2024-2032) ($MN)
  • Table 6 Global Hemorrhoid Treatment Market Outlook, By Surgical Products (2024-2032) ($MN)
  • Table 7 Global Hemorrhoid Treatment Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 8 Global Hemorrhoid Treatment Market Outlook, By Treatment Type (2024-2032) ($MN)
  • Table 9 Global Hemorrhoid Treatment Market Outlook, By Pharmacological Treatments (2024-2032) ($MN)
  • Table 10 Global Hemorrhoid Treatment Market Outlook, By Topical Treatments (2024-2032) ($MN)
  • Table 11 Global Hemorrhoid Treatment Market Outlook, By Oral Medications (2024-2032) ($MN)
  • Table 12 Global Hemorrhoid Treatment Market Outlook, By Suppositories (2024-2032) ($MN)
  • Table 13 Global Hemorrhoid Treatment Market Outlook, By Minimally Invasive Procedures (2024-2032) ($MN)
  • Table 14 Global Hemorrhoid Treatment Market Outlook, By Sclerotherapy (2024-2032) ($MN)
  • Table 15 Global Hemorrhoid Treatment Market Outlook, By Rubber Band Ligation (2024-2032) ($MN)
  • Table 16 Global Hemorrhoid Treatment Market Outlook, By Infrared Coagulation (IRC) (2024-2032) ($MN)
  • Table 17 Global Hemorrhoid Treatment Market Outlook, By Cryotherapy (2024-2032) ($MN)
  • Table 18 Global Hemorrhoid Treatment Market Outlook, By Surgical Treatments (2024-2032) ($MN)
  • Table 19 Global Hemorrhoid Treatment Market Outlook, By Hemorrhoidectomy (2024-2032) ($MN)
  • Table 20 Global Hemorrhoid Treatment Market Outlook, By Stapled Hemorrhoidopexy (2024-2032) ($MN)
  • Table 21 Global Hemorrhoid Treatment Market Outlook, By Disease Type (2024-2032) ($MN)
  • Table 22 Global Hemorrhoid Treatment Market Outlook, By Internal Hemorrhoids (2024-2032) ($MN)
  • Table 23 Global Hemorrhoid Treatment Market Outlook, By External Hemorrhoids (2024-2032) ($MN)
  • Table 24 Global Hemorrhoid Treatment Market Outlook, By Thrombosed Hemorrhoids (2024-2032) ($MN)
  • Table 25 Global Hemorrhoid Treatment Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 26 Global Hemorrhoid Treatment Market Outlook, By Pharmacies and Drugstores (2024-2032) ($MN)
  • Table 27 Global Hemorrhoid Treatment Market Outlook, By Online Pharmacies (2024-2032) ($MN)
  • Table 28 Global Hemorrhoid Treatment Market Outlook, By Healthcare Centers (2024-2032) ($MN)
  • Table 29 Global Hemorrhoid Treatment Market Outlook, By End User (2024-2032) ($MN)
  • Table 30 Global Hemorrhoid Treatment Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 31 Global Hemorrhoid Treatment Market Outlook, By Clinics (2024-2032) ($MN)
  • Table 32 Global Hemorrhoid Treatment Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
  • Table 33 Global Hemorrhoid Treatment Market Outlook, By Home Care (2024-2032) ($MN)
  • Table 34 Global Hemorrhoid Treatment Market Outlook, By Telemedicine Providers (2024-2032) ($MN)
  • Table 35 Global Hemorrhoid Treatment Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.